Actinium Pharmaceuticals's total assets for Q3 2024 were $82.11M, a decrease of -8.62% from the previous quarter. DE:7AY1 total liabilities were $43.91M for the fiscal quarter, a -4.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.